Homozygosity for the Toll-Like Receptor 2 R753Q Single-Nucleotide Polymorphism Is a Risk Factor for Cytomegalovirus Disease After Liver Transplantation

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

(2010) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

(2010) Albert J. Eid et al.   DRUGS

Functional assessment of Toll-like receptor 2 and its relevance in patients with Staphylococcus aureus infection of joint prosthesis

(2010) Odette El-Helou et al.   HUMAN IMMUNOLOGY

Cytomegalovirus infection after liver transplantation

(2010) Raymund R. Razonable   LIVER TRANSPLANTATION

R753Q Single-Nucleotide Polymorphism Impairs Toll-Like Receptor 2 Recognition of Hepatitis C Virus Core and Nonstructural 3 Proteins

(2010) Robert A. Brown et al.   TRANSPLANTATION

Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients

(2009) A. J. Eid et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The R753Q Polymorphism Abrogates Toll‐Like Receptor 2 Signaling in Response to Human Cytomegalovirus

(2009) Robert A. Brown et al.   CLINICAL INFECTIOUS DISEASES

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection

(2009) Albert J Eid et al.   TRANSPLANT INTERNATIONAL

Influence of Mannose-Binding Lectin Gene Polymorphisms on The Invasiveness of Cytomegalovirus Disease After Solid Organ Transplantation

(2009) C. Cervera et al.   TRANSPLANTATION PROCEEDINGS

Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation

(2008) N.W. Cummins et al.   Transplant Infectious Disease